Will Nutraceutical Succeed In Asking Supreme Court To Review Ephedra Ban?
This article was originally published in The Tan Sheet
Executive Summary
According to food and drug lawyer Marc Ullman, it is unlikely the Supreme Court will review the 10th Circuit Court of Appeals decision affirming FDA's ban of ephedra in dietary supplements
You may also be interested in...
Hatch, Cannon Oppose Risk-Benefit For Ephedra; Experts Discuss NPA Brief
"Nutritional supplements are not drugs and should not be regulated as such," Rep. Chris Cannon, R-Utah, said in response to inquiries about the possible review of the risk-benefit standard by the Supreme Court
Hatch, Cannon Oppose Risk-Benefit For Ephedra; Experts Discuss NPA Brief
"Nutritional supplements are not drugs and should not be regulated as such," Rep. Chris Cannon, R-Utah, said in response to inquiries about the possible review of the risk-benefit standard by the Supreme Court
Hatch, Cannon Oppose Risk-Benefit For Ephedra; Experts Discuss NPA Brief
"Nutritional supplements are not drugs and should not be regulated as such," Rep. Chris Cannon, R-Utah, said in response to inquiries about the possible review of the risk-benefit standard by the Supreme Court